; and (B) includes— (i) medication assisted treatment; (ii) treatment planning; (iii) psychiatric, psychological, or counseling services (or any combination of such services), as appropriate; (iv) social support services, as appropriate; and (v) care management and care coordination services, including coordination with other providers of services and suppliers not on an opioid use disorder care team. (b) Program design (1) In general The Secretary shall design the Program in such a manner to allow for the evaluation of the extent to which the Program accomplishes the following purposes: (A) Reduces hospitalizations and emergency department visits. (B) Increases use of medication-assisted treatment for opioid use disorders. (C) Improves health outcomes of individuals with opioid use disorders, including by reducing the incidence of infectious diseases (such as hepatitis C and HIV). (D) Does not increase the total spending on items and services under this title. (E) Reduces deaths from opioid overdose. (F) Reduces the utilization of inpatient residential treatment. (2) Consultation In designing the Program, including the criteria under subsection (e)(2)(A), the Secretary shall, not later than 3 months after the date of the enactment of this section, consult with specialists in the field of addiction, clinicians in the primary care community, and beneficiary groups. (c) Participants; opioid use disorder care teams (1) Participants (A) Definition In this section, the term participant means an entity or individual— (i) that is otherwise enrolled under this title and that is— (I) a physician (as defined in section 1861(r)(1)); (II) a group practice comprised of at least one physician described in subclause (I); (III) a hospital outpatient department; (IV) a federally qualified health center (as defined in section 1861(aa)(4)); (V) a rural health clinic (as defined in section 1861(aa)(2)); (VI) a community mental health center (as defined in section 1861(ff)(3)(B))